Here, we present a protocol to induce H-type hypertension and evaluate the antihypertensive effects of Huotan Jiedu Tongluo decoction (HTJDTLD) administered intragastrically. In rats with H-type hypertension, HTJDTLD had effective antihypertensive effects, possibly associated with inhibition of endoplasmic reticulum (ER) stress-induced apoptosis pathway activation.
H-type hypertension, which is a specific form of hypertension characterized by elevated plasma homocysteine (Hcy) levels, has become a major public health challenge worldwide. This study investigated the hypotensive effects and underlying mechanisms of Huotan Jiedu Tongluo decoction (HTJDTLD), a highly effective traditional Chinese medicine formula commonly used to treat vascular stenosis. Methionine was used to induce H-type hypertension in rats, and HTJDTLD was administered intragastrically. Then, the systolic and diastolic blood pressures of the caudal artery of rats were measured by noninvasive rat caudal manometry. Histological assessment of the aorta was performed by hematoxylin-eosin (HE) staining. Enzyme-linked immunosorbent assay (ELISA) was used to measure Hcy levels, and quantitative reverse transcriptase polymerase chain reaction (qRT-PCR) and western blotting were used to determine the mRNA and protein levels of Glucose regulatory protein 78 (GRP78), Tumor necrosis factor (TNF) receptor-associated factor 2 (TRAF2), c-Jun N-terminal kinases (JNK), and caspase-3. The results showed that HTJDTLD significantly lowered blood pressure, alleviated histopathological lesions, and decreased Hcy levels after methionine treatment. Moreover, HTJDTLD significantly inhibited the gene and protein expression of GRP78, JNK, TRAF2, and caspase 3, which are involved mainly in the endoplasmic reticulum (ER) stress-induced apoptosis pathway. Overall, the results indicated that HTJDTLD had effective antihypertensive effects in rats with H-type hypertension and revealed the antihypertensive mechanisms associated with inhibition of ER stress-induced apoptosis pathway activation.
Hypertension, a major risk factor for heart attack, stroke, and renal failure, has become a significant public health challenge that affects 1 billion people worldwide1. Homocysteine (Hcy), a thiol group-containing amino acid, is a vital metabolic intermediary of methionine metabolism. Hypertension with elevated plasma Hcy levels is defined as H-type hypertension, which could be a significant risk factor for the occurrence and recurrence of cardiocerebrovascular diseases such as stroke2,3. Recent studies have reported that the co-residency of H-type hypertension could aggravate the side effects of cardiovascular and cerebrovascular diseases4. Notably, 75% of patients in China with H-type hypertension have primary hypertension, which seriously affects the quality of life5. At present, the treatment of H-type hypertension mainly includes Western medicine. However, it may cause certain adverse effects and poor compliance and can no longer meet the needs for the comprehensive management of H-type hypertension.
Traditional Chinese medicine (TCM) is a unique resource with a history of more than 2,000 years in China. Due to the unmet need for hypertension control in Western medicine, clinicians have begun to consider the potential role of TCM in the prevention and treatment of H-type hypertension6. Huotan Jiedu Tongluo Decoction (HTJDTLD) is a traditional Chinese medicine formula formulated by Professor Yue Deng, drawing from his extensive clinical expertise7. Over the course of more than 20 years of clinical application, HTJDTLD has demonstrated remarkable effectiveness in the treatment of cardiovascular and cerebrovascular diseases1. However, whether HTJDTLD has therapeutic effects in H-type hypertension has not been reported. Therefore, we aimed to explore the antihypertensive effects and specific mechanisms of HTJDTLD in rats with H-type hypertension and identify potential therapeutic drugs for the treatment of H-type hypertension.
All animal experiments were approved by the Institutional Animal Care and Use Committee (IACUC) of Changchun University of Chinese Medicine. The materials are listed in the Table of Materials.
1. Animals and treatment
2. Blood pressure measurement
NOTE: Blood pressure measurements are performed using a noninvasive sphygmomanometer (Table of Materials).
3. Hematoxylin-eosin (HE) staining
4. Masson's trichrome staining
5. Hcy measurement by ELISA
6. RNA extraction and quantitative RT-PCR
7. Western blotting (WB)
8. Data analysis
As shown in Table 4 and Table 5, the systolic blood pressure (SBP) and diastolic blood pressure (DBP) were significantly greater in the MET group than those in the CON group from 1 to 4 weeks. After HTJDTLD treatment, the SBP and DBP of the rats were significantly lower than those in the MET group. Notably, the combined utilization of HTJDTLD and EM had a stronger antihypertensive effect than HTJDTLD treatment alone.
According to HE staining and Masson's trichrome staining, the endometrium of the aortic vessel wall was incomplete and not smooth, and the media was significantly thickened. There was smooth muscle cell proliferation and hypertrophy, the number of layers of arrangement increased, and the fibers were disordered in the MET group compared with those in the CON group. However, the vascular endometrium recovered more completely and smoothly, the media thickening was significantly reduced, and intimal damage in the MET + HTJDTLD + EM, MET + EM, and MET + HTJDTLD groups was significantly relieved (Figure 1 and Figure 2). Furthermore, the Hcy concentration in the methionine group was 2-fold greater than in the control group. However, the Hcy concentrations in the MET + HTJDTLD + EM, MET + EM, and MET + HTJDTLD groups were significantly lower than those in the MET group. Notably, the most significant reduction was found in the MET + HTJDTLD + EM group, which was approximately 1-fold lower than that in the MET group (Figure 3). The mRNA and protein expression results showed that the expression of GPR78, TRAF2, JNK, p-JNK, and caspase-3 was obviously upregulated after methionine treatment. However, HTJDTLD, EM, and the combination of HTJDTLD and EM significantly inhibited the upregulation of GPR78, TRAF2, JNK, and caspase-3. Notably, the combined application of HTJDTLD and EM had the most significant effect (Figure 4 and Figure 5).
Figure 1: HE staining. Thoracic aorta tissues histological changes from (A) CON group, (B) MET group, (C) MET + HTJDTLD + EM group, (D) MET + EM group, and (E) MET + HTJDTLD group. Nuclei are stained blue, whereas the cytoplasm and extracellular matrix have varying degrees of pink staining (100x). Please click here to view a larger version of this figure.
Figure 2: Masson staining. (A) CON group, (B) MET group, (C) MET + HTJDTLD + EM group, (D) MET + EM group and (E) MET + HTJDTLD group. Masson staining of aortic vessels in each group was performed to evaluate the effect of HTJDTLD on deposition and fibrosis (100x). Please click here to view a larger version of this figure.
Figure 3: The level of Hcy. The serum Hcy concentration of each group was detected by ELISA. Data were presented as mean ± SD (n = 6, SD are as follows: CON: 236.5 nmol/L, MET: 185 nmol/L, MET + HTJDTLD + EM: 126.8 nmol/L, MET + EM: 124 nmol/L, MET + HTJDTLD: 325 nmol/L). Please click here to view a larger version of this figure.
Figure 4: The mRNA expression of GRP78, TRAF2, JNK and caspase-3. After treatment with MET, MET + EM + HTJDTLD, and MET + EM, the expression of ERS-related genes was detected by qRT-PCR. Data were presented as mean ± SD (n = 6, SD as follows: GRP78 [CON: 0.12, MET: 0.13, MET + HTJDTLD + EM: 0.11, MET + EM: 0.17, MET + HTJDTLD: 0.12]; TRAF2 [CON: 0.09, MET: 0.09, MET + HTJDTLD + EM: 0.07, MET + EM: 0.11, MET + HTJDTLD: 0.13]; JNK [CON: 0.99, MET: 0.01, MET + HTJDTLD + EM: 0.03, MET + EM: 0.06, MET + HTJDTLD: 0.07; caspase-8 [CON: 0.06, MET: 0.10, MET + HTJDTLD + EM: 0.01, MET + EM: 0.13, MET + HTJDTLD: 0.03). * represents a significant difference compared with the CON group, # represents a significant difference compared with the MET group, Δ represents a significant difference compared with the MET + HTJDTLD group, and ∇ represents a significant difference compared with the MET + EM group. p < 0.01. Please click here to view a larger version of this figure.
Figure 5: The protein expression of GRP78, TRAF2, JNK, p-JNK and Caspase-3. (A) The protein samples were analyzed by western blotting with GRP78, TRAF2, JNK, p-JNK, and Caspase-3 antibodies. GAPDH was used as a control. (B) Quantification of GRP78, RAF2, JNK, p-JNK, and Caspase-3 proteins was determined by densitometry and has been normalized to GAPDH. Data were presented as mean ± SD (n = 6). * represents a significant difference compared with the CON group, p < 0.01. # represents a significant difference compared with the MET group, Δ represents a significant difference compared with the MET + HTJDTLD group, and ∇ represents a significant difference compared with the MET + EM group. p < 0.01. Please click here to view a larger version of this figure.
Reverse transcription reaction | |
Component | Volume (mL) |
Total RNA | 2 |
gDNA digester Mix | 3 |
SuperMix plus | 5 |
RNase-free Water | 10 |
The reaction program was as follows: 25 °C, 5 min; 55 °C, 15 min; 85 °C, 5 min. | |
RT-PCR | |
Component | Volume (mL) |
Template | 2 |
Forward Primer (10μM) | 0.4 |
Reverse Primer (10μM) | 0.4 |
Green qPCR Mix | 10 |
Nuclease-free Water | 7.2 |
The reaction program was as follows: pre-denaturation 95 °C, 5 min; denaturation 95 °C, 10 s; annealing/extension 60 °C, 45 s, for a total of 40 cycles. |
Table 1: Reverse transcription reaction volumes.
Primer name | Sequence (5’ to 3’) |
GPR78-F | CGTCGTATGTGGCCTTCACT |
GPR78-R | ATTCCAAGTGCGTCCGATGA |
TRAF2-F | GAAGGGAGCATTCCTAGACC |
TRAF2-R | GAAGGGAGCATTCCTAGACC |
JNK-F | GTCAGAATCCGAACGAGA |
JNK-R | GTCTACGCAGGCAATCG |
Caspase-3-F | GCGGTATTGAGACAGACAGTGGAAC |
Caspase-3-R | GCGGTAGAGTAAGCATACAGGAAGTC |
Table 2: List of primers.
10% separation gel, 5 mL system: | |
Component | Volume (mL) |
H2O | 1.9 |
30% acrylamide | 1.7 |
1.5 mol/L Tris-HCL (pH 8.8) | 1.3 |
10% SDS | 0.05 |
10% ammonium persulfate | 0.05 |
TEMED | 0.002 |
5% concentrated gel, 3 mL system: | |
Component | Volume (mL) |
H2O | 2.1 |
30% acrylamide | 0.5 |
1.0 mol/L Tris-HCL (pH 6.8) | 0.38 |
10% SDS | 0.03 |
10% ammonium persulfate | 0.03 |
TEMED | 0.003 |
Table 3: Composition of separation and concentrated gel.
Group | 1 week | 2 week | 3 week | 4 week |
CON | 163.4 ± 6 | 150.1 ± 7.0 | 134.2 ± 9.9 | 158.8 ± 10.2 |
MET | 192.1 ± 9.5## | 166.7 ± 12.8# | 177.3 ± 19.7## | 187 ± 23.6## |
MET+HTJDTLD+EM | 165.4 ± 9.2## | 148.9 ± 11.1* | 134.5 ± 12.3** | 159.2 ± 19.6** |
MET+EM | 173 ± 9.1## | 149.9 ± 18.7* | 145 ± 12.5** | 162.4 ± 19.1** |
MET+HTJDTLD | 176.7 ± 8.4## | 154.9 ± 22.8 | 168.3 ± 10.2 | 172.2 ± 17.4 |
Table 4: The changes in systolic pressure. #p < 0.05 and ##p < 0.01 vs. control group, *p <0.05 and **p < 0.01 vs. MET group.
Group | 1 week | 2 week | 3 week | 4 week |
CON | 138.4 ± 13.8 | 121.2 ± 12.5 | 107 ± 19.7 | 131.1 ± 16.3 |
MET | 147.9 ± 7.7# | 131 ± 11.9 | 143.7 ± 19.6## | 146 ± 21.4## |
MET+HTJDTLD+EM | 139.4 ± 10 | 123.1 ± 18.5 | 117.1 ± 9.6** | 129.2 ± 18.6** |
MET+EM | 140.9 ± 13.4 | 119.6 ± 7.8 | 123.6 ± 10.8** | 128 ± 25.2** |
MET+HTJDTLD | 140.4 ± 11.3 | 129.5 ± 11.1 | 138.3 ± 15.1 | 132.8 ± 16 |
Table 5: The changes in diastolic pressure.#p < 0.05 and ##p < 0.01 vs. control group, **p < 0.01 vs. MET group.
Hypertension is one of the most common cardiovascular disorders that affects one-third of the adult population and increases the risk of stroke, coronary heart disease, and heart and renal failure8. H-type hypertension is a special type of hypertension that refers to the co-occurrence of primary hypertension and increased homocysteine levels and has attracted broad attention over the years9. In recent years, the use of oral EM combined with antihypertensive drugs has shown improved efficacy in terms of controlling blood pressure and lowering blood Hcy levels, but there are still many contraindications, side effects, drug resistance, and other shortcomings such as headache, dizziness, fatigue, cough, and hypotension. Traditional Chinese medicine offers advantages in treating H-type hypertension through its personalized approach, addressing underlying causes, and providing complementary effects with fewer side effects, enabling effective long-term management of the condition. In this study, we found that the traditional Chinese medicine formula HTJDTLD had obviously antihypertensive effects on methionine-induced H-type hypertension. More importantly, HTJDTLD significantly enhanced the antihypertensive efficacy of EM, which is the first approved treatment for hypertension associated with elevated Hcy. However, the administration of EM sometimes produces some adverse reactions.
The level of Hcy, a sulfur-containing amino acid formed during the metabolism of methionine, is elevated in cardiovascular and neurodegenerative diseases, including hypertension10, Alzheimer’s disease, dementia11, and Parkinson’s disease12. A previous study also indicated that the interaction between hypertension and homocysteine affects the risk of mortality among middle-aged and older individuals13. Woo et al.14 reported that increased Hcy levels cause endothelial dysfunction and are associated with arterial stiffness, which is a result of destroying elastin fibers and increasing collagen production. In this study, we found that the Hcy level in plasma was significantly increased in the methionine treatment group, which was also combined with elevated blood pressure and significant arterial pathological changes. However, HTJDTLD treatment significantly lowered the blood pressure, relieved arterial pathological damage, and reduced Hcy levels. EM, a new compound preparation containing both enalapril and folic acid, served as the first approved treatment for hypertension associated with elevated Hcy15. It’s worth noting that HTJDTLD enhanced the antihypertensive effects as indicated by the decrease in Hcy levels and alleviation of pathological changes.
The endoplasmic reticulum (ER) is the central organelle for the synthesis, folding, and modification of secreted and transmembrane proteins16. Perturbation of normal ER function may lead to ER stress, which has been associated with many diseases and, more recently, hypertension17,18. Moreover, previous reports have indicated that Hcy can activate ER stress by disrupting disulfide bond formation and reducing endothelial viability and vasorelaxation19. Hcy-induced ER stress can also cause endothelial apoptosis20,21. However, whether HTJDTLD exerts antihypertensive effects by regulating ER stress has not been studied. Therefore, we explored the antihypertensive effects of HTJDTLD via the ER stress-induced apoptosis pathway. GPR78, also known as Bip, is a major chaperone and is activated after ER stress22. Tumor necrosis factor receptor-associated factor 2 (TRAF2) has also been proven to be associated with cellular responses to intrinsic signals, such as ER stress23. TRAF2 initiates signal transduction cascades, leading to the activation of c-Jun N-terminal kinase (JNK) in a cell- and context-dependent manner24. Caspase-3, a crucial executor of apoptosis, plays a pivotal role in the apoptotic process and can be activated through various pathways across various types of mammalian cells25. Caspase-3, a crucial executor of apoptosis, plays a pivotal role in the apoptotic process and can be activated through various pathways across various mammalian cell types26. Caspase-3 is involved in ER stress-mediated apoptosis and serves as the ultimate common member of different apoptotic cascades27. In this study, we detected the gene and protein expression of GPR78, TRAF2, JNK, and caspase 3 by qRT-PCR and western blotting. The results showed that methionine treatment significantly increased the gene and protein expression of GPR78, TRAF2, JNK, and caspase 3, and HTJDTLD significantly inhibited these gene and protein expression. However, there are still some limitations to using only these two methods. It may be ideal to evaluate the mechanism of action of HTJDTLD by using the inhibitor of the ERS-related signal pathway and detecting the cell apoptosis by flow cytometry. We will continue to improve our experimental protocol in future studies.
Our results indicated that HTJDTLD had antihypertensive effects in rats with methionine-induced H-type hypertension. The underlying mechanism may involve inhibiting ER stress activation-induced apoptosis. Given its antihypertensive effects and potential mechanism in rats with methionine-induced hypertension, HTJDTLD holds great promise for future therapeutic applications in the treatment of hypertension.
The authors have nothing to disclose.
This work was supported by the National Natural Science Foundation of Jilin Province (no. YDZJ202301ZYTS189).
1st Strand cDNA Synthesis SuperMix for qPCR | Yeasen,China | 11149ES | cDNA synthesis kit |
Anti-beta-actin antibody | Bioss, China | bs-0061R | |
Anti-caspase-3 antibody | Bioss, China | bs-0081R | |
Anti-GPR78 antibody | Abcam, USA | ab108513 | |
Anti-JNK antibody | Abcam, USA | ab76572 | |
Anti-p-JNK antibody | Bioss, China | bsm-52462R | |
Anti-rabbit IgG antibody | Bioss, China | bs-0295G-HRP | |
Anti-TRAF2 antibody | Bioss, China | bs-22372R | |
Bio-Rad CFX96 Touch system | Bio-Rad | CFX96 | real-time PCR detection system |
ECL Western Blot Substrates | Merck, MA, USA | WBULP-10ML | |
Enalapril maleate folic acid tablets | Yangzijiang Pharmaceutical Company, China | 20040991 | |
FastStart SYBR Green Master | Sigma | FSSGMMRO | |
Fructus Trichosanthis | The First Affiliated Hospital of Changchun University of Traditional Chinese Medicine, China | No catalog number | |
Hirudo | The First Affiliated Hospital of Changchun University of Traditional Chinese Medicine, China | No catalog number | |
intelligent noninvasive sphygmomanometer | Beijing Softron Biotechnology company | BP-2010A | |
Lonicerae Japonicae Flos | The First Affiliated Hospital of Changchun University of Traditional Chinese Medicine, China | No catalog number | |
Methionine | Sigma, USA | M9500 | |
Radix Angelicae Sinensis | The First Affiliated Hospital of Changchun University of Traditional Chinese Medicine, China | No catalog number | |
Radix et Rhizoma Glycyrrhizae | The First Affiliated Hospital of Changchun University of Traditional Chinese Medicine, China | No catalog number | |
Radix et Rhizoma Nardostachyos | The First Affiliated Hospital of Changchun University of Traditional Chinese Medicine, China | No catalog number | |
Radix et Rhizoma Rhodiolae Crenulatae | The First Affiliated Hospital of Changchun University of Traditional Chinese Medicine, China | No catalog number | |
Radix et Rhizoma Salviae Miltiorrhizae | The First Affiliated Hospital of Changchun University of Traditional Chinese Medicine, China | No catalog number | |
Radix Scrophulariae | The First Affiliated Hospital of Changchun University of Traditional Chinese Medicine, China | No catalog number | |
Rat Hcy ELISA Kits | Shanghai Meimian Industrial Company, China | MM-0293R2 | |
RIPA buffer | Shanghai Beyotime Biotechnology company | P0013B |